Dr. Pape's research interests have been in the design of therapeutic and preventive health interventions for people in resource-poor countries.
NEW YORK, NY, January 03, 2018 /24-7PressRelease/ -- Marquis Who's Who, the world's premier publisher of biographical profiles, is proud to present Jean William Pape, MD, with the Albert Nelson Marquis Lifetime Achievement Award. An accomplished listee, Dr. Pape celebrates many years' experience in his professional network, and has been noted for achievements, leadership qualities, and the credentials and successes he has accrued in his field. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.
Affiliated with Weill Cornell Medical College for over 40 years, Dr. Pape's extensive background with the prestigious organization began in 1975 when he obtained his medical degree from Cornell. In 1978, he became a Rockefeller's Foundation fellow in infectious diseases at The New York Hospital-Cornell Medical Center in New York City. Two years later, he began his journey in academia in Haiti, first as an instructor and in 1983, as an assistant professor at Weill Cornell Medicine, Cornell University. Upon his arrival in Haiti he set-up the Cornell Infectious Disease Unit at the State University Hospital in Port-au-Prince, Haiti and began serving as professor of medicine at the Medical School of Haiti. In 1989 and 1995, he was appointed respectively associate professor and professor of medicine at Weill Cornell Medicine, Cornell University. In 2012, he obtained a tenure position at Weill Cornell. He is currently the Howard and Carol Holzman Professor of Clinical Medicine at the Center for Global Health at Weill Cornell, New York, NY. He is also the Director of GHESKIO Centers in Port-au-Prince, Haiti. Dr. Pape's research interests have been in the design of therapeutic and preventive health interventions for people in resource-poor countries.
Dr. Pape earned a Bachelor's degree from Columbia University and MD at Cornell University, followed by an internship and residency at Cornell University affiliated hospitals. He served a Rockefeller fellowship in infectious diseases at The New York Hospital-Cornell Medical Center, now the New York Presbyterian/Weill Cornell Medical Center, and in 1980, after the completion of his postdoctoral training, he returned to his native Haiti to establish the Cornell Infectious Diseases Unit. Dr. Pape is noted for developing a model for the treatment of acute infantile diarrhea using oral rehydration therapy (ORT). This is the first time ORT was introduced to Haiti. The in-hospital mortality rate for children with diarrhea dropped from 44% to less than 1% within the first year at the State University Hospital, Haiti's largest public medical health center where Dr. Pape worked. Two years later, he extended his ORT treatment model nationwide with the training of over 14,000 health workers. This program is credited with Haiti's fifty percent reduction of the national infant mortality from 144/1,000 in 1982 to 70/1,000 in 1996.
Dr. Pape is also credited with the recognition and first comprehensive description of AIDS in the developing world. In 1982, because of his huge success in the treatment of children with diarrhea, Dr. Pape was asked to see adult patients with chronic diarrhea at the same hospital. They turned out to be the first AIDS cases. With nine other Haitian health professionals, Dr. Pape founded and currently serves as director of the GHESKIO Centers, the French acronym for The Haitian Study Group on Kaposi Sarcoma and Opportunistic Infections with a mission of research, training and patient care. His early research focused on modes of HIV transmission, prevention and treatment of the main opportunistic infections associated with HIV and the natural history of HIV in adults and children. GHESKIO studies on odes of HIV transmission showed that AIDS patients in Haiti had comparable risk factors as those in the USA, leading the US Centers for Disease Control and Prevention (CDC) to remove Haitians for the so called "risk groups." GHESKIO defined the epidemiology, and definitive treatment and prevention of isoporiasis and cycloporiasis in patients dually infected with HIC and tuberculosis. Twenty years later the WHO mentioned that primary INH prophylaxis in HIV-infected patients is one of the most cost effective interventions in this population.
In 2003 antiretroviral therapy (ART) became available in Haiti. GHESKIO published in the New England Journal of Medicine the first outcomes of AIDS patients on ART from the developing world. The survival rate of one thousand patients on ART in Haiti at 1 year, 5 years and 10 years was comparable to that of AIDS patients in the USA. These findings gave GHESKIO the authority to lead the national scaling up of ART in Haiti. HIV prevalence has decreased in Haiti by two-thirds to less than 2% and over 90,000 patients are receiving lifesaving ART, over one third in the GHESKIO network.
Located in Port-au-Prince, Haiti GHESKIO is the first institution in the world dedicated to the fight against HIV/AIDS, providing free and continuous medical care in Haiti since 1982. Today, GHESKIO centers is one of the largest AIDS and tuberculosis centers in the Americas, providing ART and TB care to respectively over 30,000 patients with AIDS and 3,000 patients with TB. GHESKIO successfully implemented programs to increase HIV testing and care to adolescents and high risk groups. After the 2010 massive earthquake and the country's first cholera epidemic that followed the same year, GHESKIO took a major leadership role to provide acute care and rehabilitation services to those who were severely wounded and led the efforts to control the cholera epidemic by the introduction of oral cholera vaccine and home chlorination. Microcredit programs were expanded; primary and vocational schools aimed at impoverished populations were initiated. The organization was recognized with the 2010 Gates Award for Global Health for outstanding global health service, research, and training, the Carlos Slim Research in Public Health and Institut de France's Prix Christophe Merieux. Dr. Pape also received the same year the Clinton Global Citizen award.
Dr. Pape has become an international leader in efforts to implement programs for the prevention and control of AIDS and tuberculosis in Haiti and other resource-poor countries, providing counsel to international organizations in bioethics, health disparities, and global infectious disease. Despite ongoing political turmoil, deteriorating economic conditions and natural disasters in Haiti, GHESKIO continues to provide uninterrupted care, training and to conduct translational research. New therapies and management strategies for HIV/AIDS, tuberculosis, including multiple drug resistant TB (MDRTB) and diarrhea have been validated, implemented at GHESKIO and used all over the world. A world-class vaccine and clinical trials have been established through competitive grants obtained from the US National Institutes of Health (NIH). Dr. Pape and his team have been credited with "slowing the AIDS epidemic in Haiti and serving as a model for how poor countries with few resources can combat AIDS, tuberculosis and diarrhea." (The New York Times 12/22/02).
Dr. Pape has been a member of many organizations: the Haitian National AIDS Commission since 1986, the International AIDS Society Steering Committee, (1998-2012), the National Presidential Technical Committee on Heath in Haiti, the Steering Committee of the Haitian Red Cross, (1988-2010), the Board of Trustees of the International Association of Physicians in AIDS Care (IAPAC), founder and Chair of the Trans Caribbean HIV/AIDS Research Initiative (TCHARI), the Caribbean Central America South America Network (CASSAnet), the Global Approach to Biological Research, Infectious diseases and Epidemics in Low-income countries (GABRIEL) network, the Adult AIDS Clinical trial Group Executive Committee (ACTG), (2003-2009); (2013-2016), the UNAIDS Expert Panel, (2014-Present), Chair of the National Immunization Technical Advisory Group (NITAG), Haiti, (2017-Present), Task Force against Cholera, Ministry of Health and Population, Haiti (2017-Present).
He is also on the Board of many organizations and institutions: GABRIEL (208-Present), MACAIDS (2012-Present), Institut Pasteur Global Health (2014-Present), Scientific Advisory Board of PEPFER (2015-Present), Pan American Health Organization (PAHO) Technical Group on HIC?AIDS, STI and Hepatitis (2015-Present), Institut des Sciences, des technologies et des etudes avancees d'Haïti (ISTEAH) (2015-Present), Haut Conseil Universite Quisqueye, Haiti (2017-Present).
Over the course of his career, Dr. Pape has been awarded with numerous grants for his work primarily from United Nations agencies, the National Institute of Allergy and Infectious Diseases, the Fogarty International Center, and the Centers for Disease Control and Prevention. He has over 250 publications and co-authored 22 book chapters on infectious diseases.
In 1996, GHESKIO and Dr. Pape received a special commendation, the Leon Audain's prize, from the Haitian Medical Society for their work in the prevention and control of HIV?AIDS. In 2000, Dr. Pape was honored by the Haitian-Canadian Cator Foundation as one of 10 Haitians who have made outstanding contributions to the country. Te same year, he was honored by United Nations Secretary General Kofi A. Annan at a special ceremony in the General Assembly Hall. Mr. Annan praised Dr. Pape's achievements, courage, and inspiration in contributing to breaking the silence on HIV/AIDS. In 2002, he received the "Legion D'Honneur from France, "Grade Chevalier", presented by President Jacques Chirac "for his contribution to the improvement of the health of the Haitian people and that of the people in the world". In June 2003, Dr. Pape was elected to the Unites States Institute of Medicine, now the National Academy of Science. In 2007, he received the Jonathan Mann award for Global Health and Human Rights and was the first N'Galy-Mann pioneer lecturer at the Conference on Retrovirus and Opportunistic Infections (CROI). In 2008, he received the Global Health Education Consortium annual award. The same year he obtained a Life Achievement award by Foundation Francoise Canez Auguste as "National Alive Treasure of Haiti". In 2010, he received another Life Achievement award, this time for his work on tuberculosis by the International Union against tuberculosis and Lung Disease as well as a Cornell Alumni Special recognition award. In 2014, he received the WHO Kochon award for tuberculosis and in 2015, Haiti's highest award, "Honneur et Merite, Grade Commander", from President Michel Martelly. In 2016 he obtained the International Association of Providers of AIDS Care (IAPAC), "30 year Recognition award". On December 1, 2017, "World AIDS Day", Dr. Pape received an award "Honneur et Merite" from the National AIDS Program in Haiti "for outstanding contribution in the fight against AIDS". Dr. Pape was chosen to be the first recipient of a new Cornell faculty award: "The Joan and Sanford I. Weill Cornell Exemplary Achievement Award" at a ceremony that will take place in New York on March 7, 2018.
As such, Dr. Pape has been honored by being highlighted in Who's Who in America, Who's Who in Medicine and Healthcare, Who's Who in Science and Engineering and Who's Who in the World.
In recognition of his outstanding contributions to his profession and the Marquis Who's Who community, Jean William Pape, MD, has been featured on the Albert Nelson Marquis Lifetime Achievement website. Please visit www.ltachievers.com for more information about this honor.
About Marquis Who's Who :
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America , Marquis Who's Who has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Today, Who's Who in America remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. Marquis publications may be visited at the official Marquis Who's Who website at www.marquiswhoswho.com.
# # #